Immuron Limited – American Depositary Shares (IMRN) Upgraded to Buy by Zacks Investment Research
Zacks Investment Research upgraded shares of Immuron Limited – American Depositary Shares (NASDAQ:IMRN) from a hold rating to a buy rating in a research report sent to investors on Tuesday morning. The firm currently has $14.00 target price on the stock.
According to Zacks, “Immuron Limited is a bio pharmaceutical Microbiome company. It focused on oral immunotherapy using polyclonal antibody products for humans. The company is involved in developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis. Immuron Limited is based in Armadale, Australia. “
Separately, HC Wainwright set a $15.00 target price on shares of Immuron Limited – American Depositary Shares and gave the stock a buy rating in a research note on Monday, November 20th.
WARNING: “Immuron Limited – American Depositary Shares (IMRN) Upgraded to Buy by Zacks Investment Research” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://www.watchlistnews.com/immuron-limited-american-depositary-shares-imrn-upgraded-to-buy-by-zacks-investment-research/1960045.html.
Immuron Limited – American Depositary Shares Company Profile
Immuron Limited, a microbiome company, focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. It has a technology platform that enables a shorter development therapeutic cycle.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Immuron Limited - American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immuron Limited - American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.